Grade D Patent Portfolios

88 companies with below average patent strength

Grade D means below-average patent portfolios with limited diversity or significant near-term expirations. Patent Strength Scores are calculated using USPTO PatentsView data.

Companies

4,089

Total Patents

Avg Score

88%

Of All Companies

A B C D F

All Grade D Companies

Company	Patents	Score	Expiring 2yr	Expiring 5yr
Intel	80	49	6	11
Siemens	75	48	6	9
Ford	50	48	3	5
LG	85	47	5	13
Philips	65	47	4	8
Sony	80	46	7	18
Broadcom	65	46	5	6
Boeing	60	46	2	5
Texas Instruments	60	46	3	11
Johnson & Johnson	55	46	0	8
3M	65	45	3	5
Meta	65	45	6	15
Eli Lilly	45	45	3	4
TSMC	70	44	5	15
Panasonic	70	44	7	9
Nvidia	70	44	3	10
BASF	65	44	5	9
Nokia	55	44	5	9
Roche	52	44	1	9
Medtronic	50	44	1	4
AbbVie	48	44	1	2
Ericsson	60	43	4	8
Procter & Gamble	60	43	4	9
Facebook	60	43	3	7
Cisco	55	43	4	7
Honeywell	55	43	3	5
Dow	55	43	4	7
General Motors	55	43	4	7
Oracle	50	43	1	5
HP	50	43	8	10
Merck	48	43	4	11
Boston Scientific	45	43	4	5
Danaher	40	43	0	1
Micron	55	42	3	7
Foxconn	55	42	2	6
Lockheed Martin	50	42	3	7
Applied Materials	50	42	3	6
Pfizer	50	42	3	9
Bayer	50	42	2	5
DuPont	50	42	3	7
BMW	45	42	2	8
Adobe	45	42	2	4
Thermo Fisher	45	42	2	8
BAE Systems	35	42	1	3
Novartis	55	41	3	8
AstraZeneca	48	41	4	6
Abbott	45	41	3	7
Corning	45	41	1	3
Lam Research	40	41	3	6
Dell	35	41	1	4
General Dynamics	35	41	0	3
Illumina	35	41	0	3
Raytheon	45	40	2	7
AMD	45	40	4	7
Sanofi	45	40	2	4
Deere	45	40	3	6
Lenovo	40	40	1	4
Stryker	40	40	5	6
Zimmer Biomet	35	40	1	4
PayPal	35	40	3	7
Uber	30	40	1	5
L3Harris	30	40	0	0
Bio-Rad	30	40	0	3
Becton Dickinson	30	40	2	2
Waters	25	40	1	5
Tesla	40	39	0	3
SAP	40	39	1	5
Illinois Tool Works	35	39	3	5
Agilent	35	39	2	8
Leidos	25	39	0	2
Blue Origin	20	39	2	3
Honda	50	38	5	9
Bristol-Myers Squibb	42	38	6	8
Amgen	40	38	2	6
Caterpillar	40	38	2	6
Northrop Grumman	40	38	2	3
Regeneron	38	38	3	7
Gilead	35	38	2	6
Salesforce	35	38	2	3
Baxter	35	38	0	2
Parker Hannifin	30	38	2	5
SpaceX	30	38	0	0
Roper Technologies	25	38	2	3
Visa	30	37	3	5
Mastercard	28	37	3	4
Emerson	35	36	3	6
Edwards Lifesciences	30	36	0	4
Square	25	36	2	5

Frequently Asked Questions

Grade D (Below Average) indicates below-average patent portfolios with limited diversity or significant near-term expirations. The grade is based on portfolio size (30%), claims breadth (25%), time remaining (25%), and portfolio diversity (20%).

88 of 100 tracked companies currently have a Grade D Patent Strength Score, holding a combined 4,089 patents.

Grade D companies have weaker IP protection. Investors should assess whether the company relies on patents for competitive advantage, as their portfolio may not deter competitors or generate licensing revenue.

Sources: USPTO PatentsView

Last updated: April 2026

/methodology

The this entity category groups every U.S. pharmaceutical patent expirations entity sharing this attribute. The list above is the data; the paragraphs below explain what the grouping means against the broader the FDA Orange Book and USPTO patent records distribution and how to read the relative rankings within the category.

For readers using this category as a starting point, the per-entity detail pages linked from the table above carry the underlying the FDA Orange Book and USPTO patent records data in full. The category-level view is the filter; the per-entity pages are the actual answer.

Source: USPTO patent search, 2026.